☆ 4.6 Article

Longitudinal dynamic contrast-enhanced MRI radiomic models for early prediction of response to neoadjuvant systemic therapy in triple-negative breast cancer

FRONTIERS IN ONCOLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Radiology, Nuclear Medicine & Medical Imaging

Four-Dimensional Machine Learning Radiomics for the Pretreatment Assessment of Breast Cancer Pathologic Complete Response to Neoadjuvant Chemotherapy in Dynamic Contrast-Enhanced MRI

Marco Caballo et al.

Summary: This study used spatio-temporal radiomic analysis of dynamic contrast-enhanced MRI images to identify patients achieving pathologic complete response after neoadjuvant chemotherapy for breast cancer. The results showed that there were differences in imaging phenotypes between complete and noncomplete responders, and machine learning models achieved high performance in classifying different cancer subtypes.

JOURNAL OF MAGNETIC RESONANCE IMAGING (2023)

Add to Collection

Article Multidisciplinary Sciences

Prediction of pathologic complete response to neoadjuvant systemic therapy in triple negative breast cancer using deep learning on multiparametric MRI

Zijian Zhou et al.

Summary: Deep learning based on multiparametric MRI can potentially predict TNBC patients' pCR status in the breast early during NAST.

SCIENTIFIC REPORTS (2023)

Add to Collection

Article Oncology

Assessment of Response to Neoadjuvant Systemic Treatment in Triple-Negative Breast Cancer Using Functional Tumor Volumes from Longitudinal Dynamic Contrast-Enhanced MRI

Bikash Panthi et al.

Summary: The purpose of this study was to investigate functional tumor volume measured from dynamic contrast-enhanced MRI for early assessment of neoadjuvant systemic therapy (NAST) response in triple-negative breast cancer (TNBC) patients. The results demonstrated that functional tumor volume, evaluated after 2 and 4 cycles of NAST, can serve as a non-invasive biomarker for predicting treatment response in TNBC patients.

CANCERS (2023)

Add to Collection

Article Oncology

A Radiomics Model Based on Synthetic MRI Acquisition for Predicting Neoadjuvant Systemic Treatment Response in Triple-Negative Breast Cancer

Ken -Pin Hwang et al.

Summary: A radiomics model based on quantitative maps acquired with SyMRI can be used to predict NAST response in TNBC, with high accuracy.

RADIOLOGY-IMAGING CANCER (2023)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

MRI Radiomics for Assessment of Molecular Subtype, Pathological Complete Response, and Residual Cancer Burden in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy

Sadia Choudhery et al.

Summary: This study extracted volumetric pretreatment MRI radiomics features in breast cancer patients and found that these features were associated with different molecular subtypes, pathological complete response, and residual cancer burden.

ACADEMIC RADIOLOGY (2022)

Add to Collection

Article Oncology

Pretreatment DCE-MRI-Based Deep Learning Outperforms Radiomics Analysis in Predicting Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer

Yunsong Peng et al.

Summary: This study compares the performances of deep learning (DL) and radiomics analysis (RA) in predicting pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) in breast cancer patients based on pretreatment dynamic contrast-enhanced MRI (DCE-MRI). The DL model incorporating image, kinetic, and molecular information showed the best prediction performance.

FRONTIERS IN ONCOLOGY (2022)

Add to Collection

Article Oncology

A Noninvasive Tool Based on Magnetic Resonance Imaging Radiomics for the Preoperative Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer

Chenchen Li et al.

Summary: This study aims to predict pathological complete response (pCR) in breast cancer patients using preoperative multiparametric magnetic resonance imaging (MRI). The radiomic model based on tumoral and peritumoral volumes shows promising results in predicting pCR. The study highlights the potential value of the radiomic model in breast cancer management.

ANNALS OF SURGICAL ONCOLOGY (2022)

Add to Collection

Article Medicine, General & Internal

Radiomics Analysis of Multi-Phase DCE-MRI in Predicting Tumor Response to Neoadjuvant Therapy in Breast Cancer

Shuyi Peng et al.

Summary: This study found that radiomic features extracted from each phase of pre-treatment DCE-MRI can predict tumor response in breast cancer patients undergoing neoadjuvant therapy. Using machine learning classifiers and feature selection methods, the probability of pCR in patients can be predicted effectively.

DIAGNOSTICS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Radiomics of Tumor Heterogeneity in Longitudinal Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Predicting Response to Neoadjuvant Chemotherapy in Breast Cancer

Ming Fan et al.

Summary: Breast tumor morphological and vascular characteristics can change during neoadjuvant chemotherapy (NACT), with early changes in tumor heterogeneity being quantitatively modeled using DCE-MRI to predict responses. Radiomics merging clinical and feature-level changes, when combined with molecular subtype information, significantly improves predictive performance in assessing breast tumor response to NACT.

FRONTIERS IN MOLECULAR BIOSCIENCES (2021)

Add to Collection

Article Engineering, Biomedical

Machine learning classification of texture features of MRI breast tumor and peri-tumor of combined pre- and early treatment predicts pathologic complete response

Lal Hussain et al.

Summary: This study used machine learning to classify texture features from MRI of breast tumor and molecular subtypes to predict pathological complete response to neoadjuvant chemotherapy. The combination of early treatment data and molecular subtypes significantly improved performance in predicting PCR. Longitudinal changes in texture features and peri-tumoral features further enhanced the prediction accuracy.

BIOMEDICAL ENGINEERING ONLINE (2021)

Add to Collection

Review Oncology

Triple Negative Breast Cancer: A Mountain Yet to Be Scaled Despite the Triumphs

Qitong Wu et al.

Summary: Triple-negative breast cancer (TNBC) is a highly aggressive subtype of breast cancer that cannot be treated with endocrine therapy and Her2-targeted therapy, accounting for 40% of breast cancer-related mortality. Chemoresistance, metastasis, and tumor relapse are major challenges in TNBC, with mechanisms still somewhat ambiguous. TNBC has lower survival rates compared to other breast cancer subtypes, primarily due to chemoresistance and selection of chemoresistant cells leading to distant metastasis and tumor relapse.

CANCERS (2021)

Add to Collection

Article Oncology

Radiomics of MRI for the Prediction of the Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer Patients: A Single Referral Centre Analysis

Filippo Pesapane et al.

Summary: The study aimed to predict the response to neoadjuvant chemotherapy in breast cancer patients using radiomic features extracted from MRI, in addition to biological characteristics. The combination of radiomics and clinical/biological models slightly improved the prediction of pathological complete responses, potentially helping to avoid unnecessary treatment.

CANCERS (2021)

Add to Collection

Article Oncology

Pathologic Complete Response after Neoadjuvant Chemotherapy and Impact on Breast Cancer Recurrence and Survival: A Comprehensive Meta-analysis

Laura M. Spring et al.

CLINICAL CANCER RESEARCH (2020)

Add to Collection

Article Medicine, General & Internal

Pembrolizumab for Early Triple-Negative Breast Cancer

Peter Schmid et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Multidisciplinary Sciences

MRI Radiomic Features: Association with Disease-Free Survival in Patients with Triple-Negative Breast Cancer

Sungwon Kim et al.

SCIENTIFIC REPORTS (2020)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Textural radiomic features and time-intensity curve data analysis by dynamic contrast-enhanced MRI for early prediction of breast cancer therapy response: preliminary data

Roberta Fusco et al.

EUROPEAN RADIOLOGY EXPERIMENTAL (2020)

Add to Collection

Review Oncology

Triple negative breast cancer and platinum-based systemic treatment: a meta-analysis and systematic review

Jessa Gilda P. Pandy et al.

BMC CANCER (2019)

Add to Collection

Article Oncology

Multivariate machine learning models for prediction of pathologic response to neoadjuvant therapy in breast cancer using MRI features: a study using an independent validation set

Elizabeth Hope Cain et al.

BREAST CANCER RESEARCH AND TREATMENT (2019)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Differentiation of triple-negative breast cancer from other subtypes through whole-tumor histogram analysis on multiparametric MR imaging

Tianwen Xie et al.

EUROPEAN RADIOLOGY (2019)

Add to Collection

Article Oncology

Radiomic signatures with contrast-enhanced magnetic resonance imaging for the assessment of breast cancer receptor status and molecular subtypes: initial results

Doris Leithner et al.

BREAST CANCER RESEARCH (2019)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Early Prediction of Response to Neoadjuvant Chemotherapy Using Dynamic Contrast-Enhanced MRI and Ultrasound in Breast Cancer

Yunju Kim et al.

KOREAN JOURNAL OF RADIOLOGY (2018)

Add to Collection

Review Oncology

How shall we treat early triple-negative breast cancer (TNBC): from the current standard to upcoming immuno-molecular strategies

Ji Hyun Park et al.

ESMO OPEN (2018)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Radiomic analysis of DCE-MRI for prediction of response to neoadjuvant chemotherapy in breast cancer patients

Ming Fan et al.

EUROPEAN JOURNAL OF RADIOLOGY (2017)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

DCE-MRI Texture Features for Early Prediction of Breast Cancer Therapy Response

Guillaume Thibault et al.

TOMOGRAPHY (2017)

Add to Collection

Article Oncology

Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI

Nathaniel M. Braman et al.

BREAST CANCER RESEARCH (2017)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Intratumor partitioning and texture analysis of dynamic contrast-enhanced (DCE)-MRI identifies relevant tumor subregions to predict pathological response of breast cancer to neoadjuvant chemotherapy

Jia Wu et al.

JOURNAL OF MAGNETIC RESONANCE IMAGING (2016)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Prediction of clinical phenotypes in invasive breast carcinomas from the integration of radiomics and genomics data

Wentian Guo et al.

JOURNAL OF MEDICAL IMAGING (2015)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Multiparametric Magnetic Resonance Imaging for Predicting Pathological Response After the First Cycle of Neoadjuvant Chemotherapy in Breast Cancer

Xia Li et al.

INVESTIGATIVE RADIOLOGY (2014)

Add to Collection

Article Oncology

Comparison of dynamic contrast-enhanced MR, ultrasound and optical imaging modalities to evaluate the antiangiogenic effect of PF-03084014 and sunitinib

Cathy C. Zhang et al.

CANCER MEDICINE (2014)

Add to Collection

Article Oncology

Neoadjuvant treatment of breast cancer

A. M. Thompson et al.

ANNALS OF ONCOLOGY (2012)

Add to Collection

Article Medicine, Research & Experimental

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

Brian D. Lehmann et al.

JOURNAL OF CLINICAL INVESTIGATION (2011)

Add to Collection

Article Oncology

Magnetic Resonance Imaging Response Monitoring of Breast Cancer During Neoadjuvant Chemotherapy: Relevance of Breast Cancer Subtype

Claudette E. Loo et al.

JOURNAL OF CLINICAL ONCOLOGY (2011)

Add to Collection

Review Medicine, General & Internal

Triple-Negative Breast Cancer

William D. Foulkes et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Add to Collection

Article Oncology

Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer

Cornelia Liedtke et al.

JOURNAL OF CLINICAL ONCOLOGY (2008)

Add to Collection

Review Radiology, Nuclear Medicine & Medical Imaging

Dynamic contrast enhanced magnetic resonance imaging in oncology: Theory, data acquisition, analysis, and examples

Thomas E. Yankeelov et al.

CURRENT MEDICAL IMAGING REVIEWS (2007)

Add to Collection

Article Oncology

Descriptive analysis of estrogen receptor (ER)negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype - A population-based study from the California Cancer Registry

Katrina R. Bauer et al.

CANCER (2007)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy

EL Rosen et al.

AMERICAN JOURNAL OF ROENTGENOLOGY (2003)

Add to Collection

Review Radiology, Nuclear Medicine & Medical Imaging

MRI of the tumor microenvironment

RJ Gillies et al.

JOURNAL OF MAGNETIC RESONANCE IMAGING (2002)

Add to Collection

© Peeref 2019-2024. All rights reserved.